These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31672614)

  • 41. Optimization of Olive Oil-Based Nanoemulsion Preparation for Intravenous Drug Delivery.
    Karami Z; Khoshkam M; Hamidi M
    Drug Res (Stuttg); 2019 May; 69(5):256-264. PubMed ID: 30086568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fosphenytoin.
    Eriksson K; Keränen T; Kälviäinen R
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):695-701. PubMed ID: 19473113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.
    Ogutu BR; Newton CR; Muchohi SN; Otieno GO; Edwards G; Watkins WM; Kokwaro GO
    Br J Clin Pharmacol; 2003 Jul; 56(1):112-9. PubMed ID: 12848783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting.
    Kumar M; Misra A; Mishra AK; Mishra P; Pathak K
    J Drug Target; 2008 Dec; 16(10):806-14. PubMed ID: 18988064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fosphenytoin.
    Luer MS
    Neurol Res; 1998 Mar; 20(2):178-82. PubMed ID: 9522355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical phenytoin nanostructured lipid carriers: design and development.
    Motawea A; Borg T; Abd El-Gawad AEH
    Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.
    Shelke S; Shahi S; Jalalpure S; Dhamecha D
    J Liposome Res; 2016 Dec; 26(4):313-23. PubMed ID: 26758957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol.
    Bebin M; Bleck TP
    Drugs; 1994 Aug; 48(2):153-71. PubMed ID: 7527321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of Morin-Loaded Nanoemulsions Containing Various Polymers; Role of Polymers in Formulation Properties and Bioavailability.
    Ikeuchi-Takahashi Y; Murata S; Murata W; Kobayashi A; Ishihara C; Onishi H
    AAPS PharmSciTech; 2020 May; 21(5):150. PubMed ID: 32435858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nasal in-situ gels for delivery of rasagiline mesylate: improvement in bioavailability and brain localization.
    Ravi PR; Aditya N; Patil S; Cherian L
    Drug Deliv; 2015; 22(7):903-10. PubMed ID: 24286183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation.
    Hosny KM; Hassan AH
    Int J Pharm; 2014 Nov; 475(1-2):191-7. PubMed ID: 25178831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Formulation and evaluation of cholesterol-rich nanoemulsion (LDE) for drug delivery potential of cholesteryl-maleoyl-5-fluorouracil.
    Alanazi FK; Haq N; Radwan AA; Alsarra IA; Shakeel F
    Pharm Dev Technol; 2015 May; 20(3):266-70. PubMed ID: 24266739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fosphenytoin use in children.
    Pellock JM
    Neurology; 1996 Jun; 46(6 Suppl 1):S14-6. PubMed ID: 8649608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Population Pharmacokinetic Analysis of Phenytoin After Intravenous Administration of Fosphenytoin in Adult and Elderly Epileptic Patients.
    Higuchi K; Yamashita D; Kashihara Y; Kakara M; Hirota T; Hirakawa M; Ieiri I
    Ther Drug Monit; 2019 Oct; 41(5):674-680. PubMed ID: 31095070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of phenytoin following intravenous and intramuscular administration of fosphenytoin and phenytoin sodium in the rabbit.
    Muchohi SN; Kokwaro GO; Maitho TE; Munenge RW; Watkins WM; Edwards G
    Eur J Drug Metab Pharmacokinet; 2002; 27(2):83-9. PubMed ID: 12064376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mathematical models to calculate fosphenytoin concentrations in the presence of phenytoin using phenytoin immunoassays and alkaline phosphatase.
    Dasgupta A; Handy BC; Datta P
    Am J Clin Pathol; 2000 Jan; 113(1):87-92. PubMed ID: 10631861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide.
    Morsi N; Ibrahim M; Refai H; El Sorogy H
    Eur J Pharm Sci; 2017 Jun; 104():302-314. PubMed ID: 28433750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formulation characterization and in vitro drug release of hydrogel-thickened nanoemulsions for topical delivery of 8-methoxypsoralen.
    Barradas TN; Senna JP; Cardoso SA; de Holanda E Silva KG; Elias Mansur CR
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():245-253. PubMed ID: 30184748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fosphenytoin: a novel phenytoin prodrug.
    Boucher BA
    Pharmacotherapy; 1996; 16(5):777-91. PubMed ID: 8888074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
    Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD
    Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.